1. Home
  2. IPSC vs NEUE Comparison

IPSC vs NEUE Comparison

Compare IPSC & NEUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • NEUE
  • Stock Information
  • Founded
  • IPSC 2019
  • NEUE 2015
  • Country
  • IPSC United States
  • NEUE United States
  • Employees
  • IPSC N/A
  • NEUE N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • NEUE
  • Sector
  • IPSC Health Care
  • NEUE
  • Exchange
  • IPSC Nasdaq
  • NEUE NYSE
  • Market Cap
  • IPSC 58.1M
  • NEUE 60.7M
  • IPO Year
  • IPSC 2021
  • NEUE 2021
  • Fundamental
  • Price
  • IPSC $0.54
  • NEUE $6.40
  • Analyst Decision
  • IPSC Strong Buy
  • NEUE Hold
  • Analyst Count
  • IPSC 5
  • NEUE 1
  • Target Price
  • IPSC $3.67
  • NEUE $7.00
  • AVG Volume (30 Days)
  • IPSC 551.0K
  • NEUE 19.3K
  • Earning Date
  • IPSC 05-08-2025
  • NEUE 05-07-2025
  • Dividend Yield
  • IPSC N/A
  • NEUE N/A
  • EPS Growth
  • IPSC N/A
  • NEUE N/A
  • EPS
  • IPSC N/A
  • NEUE N/A
  • Revenue
  • IPSC $6,589,000.00
  • NEUE $936,657,000.00
  • Revenue This Year
  • IPSC $833.10
  • NEUE $33.99
  • Revenue Next Year
  • IPSC N/A
  • NEUE $5.90
  • P/E Ratio
  • IPSC N/A
  • NEUE N/A
  • Revenue Growth
  • IPSC 194.81
  • NEUE N/A
  • 52 Week Low
  • IPSC $0.34
  • NEUE $3.79
  • 52 Week High
  • IPSC $3.70
  • NEUE $7.66
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 53.48
  • NEUE 48.94
  • Support Level
  • IPSC $0.34
  • NEUE $6.03
  • Resistance Level
  • IPSC $0.54
  • NEUE $6.84
  • Average True Range (ATR)
  • IPSC 0.05
  • NEUE 0.34
  • MACD
  • IPSC 0.02
  • NEUE 0.03
  • Stochastic Oscillator
  • IPSC 93.95
  • NEUE 48.86

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

About NEUE NEUEHEALTH INC

NeueHealth Inc is a value driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. It also enables independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally.

Share on Social Networks: